Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at raps@raps.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The Learning Portal will be under maintenance Monday, 6 December between 6 AM and 5 PM EST. Portal functionality will be unavailable during this window. We apologize for any inconvenience caused during this time.
Posted 03 January 2012 | By Alexander Gaffney, RAC
UK Health Secretary Andrew Lansley launched an investigation in to breast implants made by the now-bankrupt French Poly Implant Prothese (PIP) on 31 December, saying that he wants to "reassure women […] that we will act swiftly to help them."
Some 40,000 British women have the implants, which reports have claimed are rupturing at excessively high rates. Britain's Medicines and Healthcare Products Regulatory Agency (MHRA) is now slated to re-review the device and associated safety data.
The French regulatory authority, AFSSAPS, has outlined several issues with the breast implants, including the use of unapproved, industrial grade silicone and a higher-than-anticipated rupture rate.
Tags: Andrew Lansley, Rupture, Breast Implant, Poly Implant Prothese, AFSSAPS, Silicone, PIP, Latest News
Regulatory Focus newsletters
All the biggest regulatory news and happenings.